Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children

Journal of Infection

Volumn 63, Issue 4, 2011, Pages 288-294

  Sugaya, Norio ^a   Shinjoh, Masayoshi ^b   Mitamura, Keiko ^c   Takahashi, Takao ^b  

^a Keiyu Hospital   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Public Interest Foundation Corporation Life Extension Laboratory Attached Eiju General Hospital   (Japan)

Author keywords

Influenza; Mortality rate; Neuraminidase inhibitor; Paediatric inpatients; Pandemic influenza A (H1N1) 2009

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; NEURAMINIDASE; OSELTAMIVIR; RETROSPECTIVE STUDIES; TIME FACTORS; VIRAL PROTEINS; YOUNG ADULT;

EID: 80052935987     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.06.008     Document Type: Article

References (32)

1. Welfare and labour, Japan. Infect Dis Weekly Rep Japan (IDWR) 2010, 12:10-15. Ministry of Health, Available at. http://idsc.nih.go.jp/idwr/kanja/idwr/idwr2010/idwr2010-10.pdf.
2. Ministry of Health, Welfare and Labour, Japan. Age distribution of fatal cases due to 2009 pandemic influenza A(H1N1) in Japan. Available at, http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/rireki/100331-03.html.
3. Louie J.K., Acosta M., Jamieson D.J., Honein M.A. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2009, 362(1):27-35.
4. Ministry of Health, Welfare and Labour, Japan. Vital Statistics of Japan. Available at, http://www.e-stat.go.jp/SG1/estat/GL08020101.do?_toGL08020101_%26tstatCode=000001028897%26requestSender=dsearch.
5. Centers for Disease Control and Prevention, CDC Estimates of 2009 H1N1 Cases and Related Hospitalizations and Deaths from April 2009 through April 10, 2010, By Age Group. Available at, http://www.cdc.gov/h1n1flu/pdf/graph_April%25202010N.pdf.
6. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353(24):2559-2567.
7. Libster R., Bugna J., Coviello S., Hijano D.R., Dunaiewsky M., Reynoso N., et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010, 362(1):45-55.
8. Stein M., Tasher D., Glikman D., Shachor-Meyouhas Y., Barkai G., Yochai A.B., et al. Hospitalization of children with influenza A(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey. Arch Pediatr Adolesc Med 2010, 164(11):1015-1022.
9. van't Klooster T.M., Wielders C.C., Donker T., Isken L., Meijer A., van den Wijngaard C.C., et al. Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June-31 December 2009. Euro Surveill 2010, 15(2).
10. Sachedina N., Donaldson L.J. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet 2010, 376(9755):1846-1852.
11. Sugaya N., Mitamura K., Yamazaki M., Tamura D., Ichikawa M., Kimura K., et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007, 44(2):197-202.
12. Sugaya N., Tamura D., Yamazaki M., Ichikawa M., Kawakami C., Kawaoka Y., et al. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 2008, 47(3):339-345.
13. Ministry of Health, Welfare and Labour, Japan. Flash report of influenza virus in Japan, 2009/10 season (seasonal + AH1pdm). Infectious Agents Surveillance Report. Available at, http://idsc.nih.go.jp/iasr/influ-e.html.
14. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009, 58(30):826-829.
15. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302(17):1896-1902.
16. Sakai-Tagawa Y., Ozawa M., Tamura D., Le M.Q., Nidom C.A., Sugaya N., et al. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol 2010, 48(8):2872-2877.
17. WHO, WHO Rapid Advice Guidelines for Pharmacological Management of Pandemic Influenza (H1N1) 2009 and other Influenza Viruses. Available at, http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf.
18. Centers for Disease Control and Prevention, Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. Available at, http://www.cdc.gov/H1N1flu/recommendations.htm%23b.
19. Scottish Intercollegiate Guidelines Network, Bronchiolitis in Children, Guideline No. 91. Available at, http://www.sign.ac.uk/guidelines/fulltext/91/index.html.
20. New concerns about oseltamivir. Lancet 2007, 369(9567):1056.
21. Sugaya N., Nerome K., Ishida M., Nerome R., Nagae M., Takeuchi Y., et al. Impact of influenza virus infection as a cause of pediatric hospitalization. J Infect Dis 1992, 165(2):373-375.
22. Sugaya N., Mitamura K., Nirasawa M., Takahashi K. The impact of winter epidemics of influenza and respiratory syncytial virus on paediatric admissions to an urban general hospital. J Med Virol 2000, 60(1):102-106.
23. Louie J.K., Gavali S., Acosta M., Samuel M.C., Winter K., Jean C., et al. Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med 2010, 164(11):1023-1031.
24. The Japanese Association for Infectious Diseases, Recommendation for Treatment of H1N1 Pandemic Influenza. Available at, http://www.kansensho.or.jp/topics/100122soiv_teigen.html.
25. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361(20):1935-1944.
26. Dominguez-Cherit G., Lapinsky S.E., Macias A.E., Pinto R., Espinosa-Perez L., de la Torre A., et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302(17):1880-1887.
27. Zarychanski R., Stuart T.L., Kumar A., Doucette S., Elliott L., Kettner J., et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010, 182(3):257-264.
28. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E., Mytton O.T., Pebody R.G., et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009, 339:b5213.
29. Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., Uyeki T.M., et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362(18):1708-1719.
30. Kumar S., Havens P.L., Chusid M.J., Willoughby R.E., Simpson P., Henrickson K.J. Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J 2010, 29(7):591-594.
31. O'Riordan S., Barton M., Yau Y., Read S.E., Allen U., Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010, 182(1):39-44.
32. Liu A.H., Cover R.A., Spahn J.D., Leung D.Y.M. Childhood asthma. Nelson textbook of pediatrics 2007, 953-970. Saunders, Philadelphia, Elsevier. 18th ed. R.M. Kliegman, R.E. Behrman, H.D. Jenson, B.F. Stanton (Eds.).